Evidence map›Paper›PMID 30657872›Full record

ArticleBioinformatics (Oxford, England)2019

AllerCatPro-prediction of protein allergenicity potential from the protein sequence.

Sebastian Maurer-Stroh, Nora L Krutz, Petra S Kern, Vithiagaran Gunalan, Minh N Nguyen, Vachiranee Limviphuvadh, Frank Eisenhaber, G Frank Gerberick

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Frontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk analysis approaches for microbial ingredients in microbial-based cleaning products.Risk analysis : an official publication of the Society for Risk Analysis · 2025
    Article
  12. Article
  13. IntegratingCurrent research in food science · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. AnCurrent computer-aided drug design · 2025
    Article
  18. Article
  19. Review
  20. De Novo Transcriptomic Analyses to Identify and Compare Allergens in Foods.Methods in molecular biology (Clifton, N.J.) · 2024
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sebastian Maurer-StrohBiomolecular Function Discovery Division, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore.
Nora L KrutzThe Procter & Gamble Services Company, Strombeek-Bever, Belgium.
Petra S KernThe Procter & Gamble Services Company, Strombeek-Bever, Belgium.
Vithiagaran GunalanBiomolecular Function Discovery Division, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore.
Minh N NguyenBiomolecular Function Discovery Division, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore.
Vachiranee LimviphuvadhBiomolecular Function Discovery Division, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore.
Frank EisenhaberBiomolecular Function Discovery Division, Bioinformatics Institute, Agency for Science, Technology and Research, Singapore.
G Frank GerberickThe Procter and Gamble Company, Mason, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationDue to the risk of inducing an immediate Type I (IgE-mediated) allergic response, proteins intended for use in consumer products must be investigated for their allergenic potential before introduction into the marketplace. The FAO/WHO guidelines for computational assessment of allergenic potential of proteins based on short peptide hits and linear sequence window identity thresholds misclassify many proteins as allergens.

resultsWe developed AllerCatPro which predicts the allergenic potential of proteins based on similarity of their 3D protein structure as well as their amino acid sequence compared with a data set of known protein allergens comprising of 4180 unique allergenic protein sequences derived from the union of the major databases Food Allergy Research and Resource Program, Comprehensive Protein Allergen Resource, WHO/International Union of Immunological Societies, UniProtKB and Allergome. We extended the hexamer hit rule by removing peptides with high probability of random occurrence measured by sequence entropy as well as requiring 3 or more hexamer hits consistent with natural linear epitope patterns in known allergens. This is complemented with a Gluten-like repeat pattern detection. We also switched from a linear sequence window similarity to a B-cell epitope-like 3D surface similarity window which became possible through extensive 3D structure modeling covering the majority (74%) of allergens. In case no structure similarity is found, the decision workflow reverts to the old linear sequence window rule. The overall accuracy of AllerCatPro is 84% compared with other current methods which range from 51 to 73%. Both the FAO/WHO rules and AllerCatPro achieve highest sensitivity but AllerCatPro provides a 37-fold increase in specificity. AVAILABILITY AND IMPLEMENTATION: https://allercatpro.bii.a-star.edu.sg/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Food HypersensitivityAllergensAmino Acid SequenceDatabases, ProteinHumansProteinsSequence AlignmentAllergensProteins

Identifiers

PMID30657872
PMCPMC6736023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.